Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil- and water-soluble multivitamin with minerals tablets.
The goal of this study is to characterize the formulation and processing factors that influence folic acid dissolution from oil- and water-soluble multivitamin with minerals tablet formulations for direct compression. The following parameters were studied: bulk filler solubility, soluble to insoluble bulk filler ratio, triturating agent (preblending carrier) solubility, disintegrant usage, compression pressure, and folic acid particle size. Folic acid particle size was determined by using light microscopy, and surface area was measured by using BET adsorption. The tablets were compressed on an instrumented Stokes B2 tablet press, and the friability, weight variation, and dissolution were measured according to USP methods, along with tablet breaking strength. In summary, we found the following factors to be critical to folic acid dissolution: bulk filler solubility (soluble fillers, such as maltose, increase folic acid dissolution); disintegrant amount (levels less than 0.4% (w/w) are ineffectual, whereas levels greater than 1.2% (w/w) did not further increase dissolution); and compression force (generally, maltose produce harder tablets). In addition, folic acid dissolution was less affected by changes in compaction pressure when a "super" disintegrant and maltose, as a bulk filler, were used. It was determined that the trituration agent did not play a significant role in folic acid dissolution. In the range of parameters studied, statistical analysis found no significant interactions between the parameters studied, which means they act independently in an additive manner. The results also show that no one factor is completely responsible for dissolution failure. Thus, it is the combination of formulation factors and processing conditions that collectively add up to produce dissolution failure; however, the use of a disintegrant and a soluble filler such as maltose can make a formulation more robust to the inevitable changes that can occur during commercial production.
Du
Jianping
J
Department of HACO, Wyle Laboratories, Life Sciences Systems and Services, Houston, Texas, USA.
Hoag
Stephen W
SW
D019587:Dietary Supplements; D005079:Excipients / Q000737:chemistry*; D005492:Folic Acid / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006397:Hematinics / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008903:Minerals / Q000008:administration & dosage; D009821:Oils; D012995:Solubility; D013607:Tablets; D014815:Vitamins / Q000008:administration & dosage; D014867:Water
D005079:Excipients; D006397:Hematinics; D008903:Minerals; D009821:Oils; D013607:Tablets; D014815:Vitamins; D014867:Water; D005492:Folic Acid